By using lab tests and doctor checks together, we can make B12 treatment better for our patients
Without proper quality control, these drugs may also be stored or shipped under conditions that degrade their potency, further compromising safety and efficacy
There are no legitimate long-term data to support it
In ten years of raw material qualification, we have found this simple sensory check to be highly predictive of mislabeled or degraded inventory
For someone with Crohn's disease or ulcerative colitis, distinguishing between medication side effects and disease flares becomes genuinely difficult
In September 2024, Hikma Pharmaceuticals PLC finalized the acquisition of Xellia Pharmaceuticals US finished dosage form business with a deal including a facility in Ohio, Sales and marketing capabilities, and an R&D center in Croatia, aiming to strengthen the commercial portfolio and production supplements